Detalhe da pesquisa
1.
Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial.
Am Heart J
; 237: 68-78, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676886
2.
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.
Diabetes Obes Metab
; 23(12): 2707-2715, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402161
3.
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
N Engl J Med
; 375(25): 2423-2434, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959713
4.
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection.
Clin Microbiol Infect
; 29(10): 1320-1327, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422079
5.
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Clin Infect Dis
; 46(5): 647-55, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18225981
6.
Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding.
Acad Emerg Med
; 23(2): 144-50, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26765080
7.
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
J Clin Oncol
; 21(22): 4112-9, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14559886
8.
Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence.
J Urol
; 176(6 Pt 1): 2535-40; discussion 2540, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17085151
9.
Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.
Cancer
; 104(4): 864-8, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15973669